Discontinued — last reported Q2 '22
Merck & Co. Deferred Taxes decreased by 289.2% to -$825.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 33.9%, from -$616.00M to -$825.00M. Over 4 years (FY 2021 to FY 2025), Deferred Taxes shows a downward trend with a 72.9% CAGR.
Significant changes can indicate shifts in tax strategy, capital investment timing, or changes in accounting estimates.
Deferred income taxes represent the temporary differences between the tax expense reported on the income statement and t...
Standard line item for all large corporations subject to complex tax jurisdictions.
cf_deferred_income_taxes| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $39.00M | -$1.00M | $159.00M | -$338.00M | -$262.00M | -$661.00M | -$307.00M | -$277.00M | -$355.00M | -$336.00M | -$931.00M | -$51.00M | -$181.00M | -$401.00M | -$616.00M | -$186.00M | -$448.00M | -$212.00M | -$825.00M |
| QoQ Change | — | -102.6% | >999% | -312.6% | +22.5% | -152.3% | +53.6% | +9.8% | -28.2% | +5.4% | -177.1% | +94.5% | -254.9% | -121.5% | -53.6% | +69.8% | -140.9% | +52.7% | -289.2% |
| YoY Change | — | — | — | — | -771.8% | <-999% | -293.1% | +18.0% | -35.5% | +49.2% | -203.3% | +81.6% | +49.0% | -19.3% | +33.8% | -264.7% | -147.5% | +47.1% | -33.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.